investor relations
Matthew Parrish
Head of Investor Relations
Email: matthew.parrish@clinigengroup.com
Telephone: +44 1932 825 498
This website uses cookies. By continuing to access the site you are agreeing to their use. Learn more about cookies.
Online services for healthcare professionals
Hard to find medicines (Clinigen Direct) Managed Access Programs (Cliniport) Commercial Medicines Special Obtains Aseptics UKMatthew Parrish
Head of Investor Relations
Email: matthew.parrish@clinigengroup.com
Telephone: +44 1932 825 498